Condensed Consolidated Interim Statement of Financial Position as at June 30, 2026 | Notes Jun. 30, 2026 Dec. 31, 2025 | Assets | Cash and balances at the central bank 14 144,083,579 88,876,452 | Due from banks 15 213,509,638 135,236,549 | Loans and advances to banks, net 17 48,462,194 34,440,770 | Loans and advances to customers, net 18 597,785,831 507,953,766 | Derivative financial instruments 399,402 620,349 | Financial investments | - Financial Assets at Fair Value through OCI 19.1 348,654,793 376,397,929 | - Financial Assets at Amortized cost 19.1 269,977,831 236,672,175 | Investments in associates 20 51,807 45,210 | Non-current assets held for sale 32 190,054 182,827 | Other assets 21 58,636,578 54,040,912 | Deferred tax assets 2,437,842 2,545,499 | Property and equipment 22 5,850,379 5,481,682 | Total assets 1,690,039,928 1,442,494,120 | Liabilities and equity | Liabilities | Due to banks 23 42,856,364 3,353,746 | Due to customers 24 1,308,646,344 1,110,395,693 | Non-current liabilities held for sale 33 54,956 53,860 | Derivative financial instruments 227,032 137,802 | Current income tax liabilities 12,351,399 20,570,313 | Other liabilities 25 32,905,897 25,595,390 | Issued debt instruments 26 4,922,120 4,761,558 | Other loans 34,616,250 30,471,499 | Other provisions 27 15,043,327 15,640,041 | Total liabilities 1,451,623,689 1,210,979,902 | Equity | Issued and paid capital 34,051,391 33,779,361 | Reserves 136,938,489 105,849,176 | Reserve for employee stock ownership plan (ESOP) 2,295,868 2,343,532 | Retained earnings* 65,117,363 89,514,273 | Total equity and net profit for the period / year 238,403,111 231,486,342 | Non-Controlling Interest 13,128 27,876 | Total NCI, equity and net profit for the period / year 238,416,239 231,514,218 | Total liabilities and equity 1,690,039,928 1,442,494,120 | The accompanying notes are an integral part of these financial statements. | (Review report attached) | * Including net profit for the period | Islam Zekry Hisham Ezz Al-Arab | Group CFO & Executive Board Member CEO & Executive Board Member |
Condensed Consolidated Interim Income Statement for The Period Ended June 30, 2026 | Last 6 Months Last 6 Months | Notes Jun. 30, 2026 Jun. 30, 2025 | Interest and similar income 110,568,003 105,160,947 | Interest and similar expense (49,741,855) (53,825,527) | Net interest income 60,826,148 51,335,420 | Fee and commission income 10,042,456 7,444,430 | Fee and commission expense (4,214,535) (3,294,001) | Net fee and commission income 5,827,921 4,150,429 | Dividend income 186,093 39,083 | Net trading income 9 1,455,384 1,247,489 | Profits (losses) on financial investments 19.2 545,790 622,565 | Administrative expenses (10,356,040) (7,915,569) | Other operating income (expenses) 10 (3,850,419) (3,558,772) | Release (charges) for ECL 11 (482,430) 333,558 | Bank's share in the profits (losses) of associates 6,597 5,489 | Profit before income tax 54,159,044 46,259,692 | Income tax expense 12 (14,495,340) (13,462,229) | Deferred tax assets (liabilities) 12 (349,978) 549,173 | Net profit for the period 39,313,726 33,346,636 | Non-Controlling Interest 267 946 | Bank's shareholders 39,313,459 33,345,690 | Earnings per share 13 | Basic 10.23 8.82 | Diluted 10.11 8.71 | Islam Zekry Hisham Ezz Al-Arab | Group CFO & Executive Board Member CEO & Executive Board Member |
Condensed Consolidated Interim Statement of Comprehensive Income for The Period Ended June 30, 2026 | Last 6 Months Last 6 Months | Jun. 30, 2026 Jun. 30, 2025 | Net profit for the period 39,313,726 33,346,636 | Transferred to RE from financial assets at fair value through OCI - 3,586 | Net change on financial assets at fair value through comprehensive income after tax (3,867,224) 5,056,845 | Cumulative foreign currencies translation differences 383,255 (215,827) | Effect of ECL on debt instruments measured at fair value through OCI (942,320) 142,274 | Total comprehensive income for the period 34,887,437 38,333,514 | As follows: | Bank's shareholders 34,887,170 38,250,562 | Non-Controlling Interest 267 82,952 | Total comprehensive income for the period 34,887,437 38,333,514 |
Condensed Consolidated Interim Cash Flows for The Period Ended June 30, 2026 | Notes Jun. 30, 2026 Jun. 30, 2025 | Cash flow from operating activities | Profit before income tax 54,159,044 46,259,692 | Adjustments to reconcile profits to net cash provided by operating activities | Fixed assets depreciation 22 1,187,993 1,199,285 | Impairment release/charge for credit losses (loans and advances to customers and banks) 11 784,879 (853,542) | Net charge/release for other provisions 27 589,360 1,028,755 | Impairment release/charge for credit losses (due from banks) 11 13,971 143,346 | Impairment release/charge for credit losses (financial investments) 11 (316,420) 376,638 | Exchange revaluation differences for financial assets at fair value through OCI and AC (7,418,211) 1,489,447 | Revaluation differences impairment charge for Financial Assets at Fair value through OCI 193,153 (92,993) | Revaluation differences impairment charge for Financial Assets at Amortized cost (28,515) 1,638 | Revaluation differences impairment charge for due from banks 3,638 (2,865) | Net utilized/recovered for other provisions 27 (1,190,515) (1,053) | Exchange revaluation differences of other provisions 27 4,441 291,117 | Profits/losses from selling property and equipment - (6,006) | Profits/losses from selling financial investments at fair value through OCI 19.2 (545,790) (345,157) | Profits/losses from selling investments in associates 19.2 - (277,408) | Share based payments 795,382 653,254 | Bank's share in the profits/losses of associates (6,597) (5,489) | Operating profits before changes in operating assets and liabilities 48,225,813 49,858,659 | Net decrease / increase in assets and liabilities | Due from banks (47,677,179) 77,313,672 | Derivative financial instruments 295,040 24,358 | Loans and advances to banks and customers (104,639,422) (96,538,045) | Other assets (3,252,185) (5,571,542) | Non-current assets held for sale 32 (7,227) - | Due to banks 23 39,502,618 956,522 | Due to customers 24 198,250,651 72,729,202 | Current income tax obligations paid (2,143,941) (2,089,122) | Non-current liabilities held for sale 33 1,096 (35) | Other liabilities (12,876,550) (13,007,521) | Net cash generated from (used in) operating activities 115,678,714 83,676,148 | Cash flow from investing activities | Proceeds from sale of investments in associates - 339,920 | Payments for purchases of property, equipment and branches construction (2,899,117) (4,828,546) | Proceeds from selling property and equipment 10 - 6,006 | Proceeds from redemption of financial assets at amortized cost 11,995,898 4,937,562 | Payments for purchases of financial assets at amortized cost (45,916,509) (48,979,866) | Payments for purchases of financial assets at fair value through OCI (83,415,699) (91,406,698) | Proceeds from selling financial assets at fair value through OCI 114,838,479 65,127,965 | Net cash generated from (used in) investing activities (5,396,948) (74,803,657) | Condensed Consolidated Interim Cash Flows for The Period Ended June 30, 2026 (Cont.) | Jun. 30, 2026 Jun. 30, 2025 | Cash flow from financing activities | Other loans 4,144,751 7,288,192 | Dividends (29,052,828) (14,219,571) | Issued debt instruments 160,562 (118,817) | Capital increase 272,030 276,930 | Net cash generated from (used in) financing activities (24,475,485) (6,773,266) | Net increase (decrease) in cash and cash equivalent during the period 85,806,281 2,099,225 | Beginning balance of cash and cash equivalent 140,542,556 226,610,721 | Cash and cash equivalent at the end of the period 226,348,837 228,709,946 | Cash and cash equivalent comprise: | Cash and balances at the central bank 14 144,083,579 101,492,185 | Due from banks 213,659,929 231,671,573 | Treasury bills and other governmental notes 16 151,392,107 124,383,524 | Obligatory reserve balance with central bank (123,872,640) 0 (76,444,950) | Due from banks with maturity more than three months (7,522,252) (28,050,433) | Treasury bills and other governmental notes with maturity more than three months (151,391,886) (124,341,953) | Total cash and cash equivalent 226,348,837 228,709,946 |
Condensed Consolidated Interim Statement of Changes in Shareholders' Equity | Jun. 30, 2025 Issued and paid capital Legal reserve General reserve General risk reserve Special reserve Reserve for transactions under common control Capital reserve Reserve for financial assets at fair value through OCI Banking risks reserve Retained earnings Reserve for employee stock ownership plan Cumulative foreign currencies translation differences Total Shareholders' Equity Non-Controlling Interest Total | Beginning balance 30,431,580 6,208,674 62,422,792 1,550,906 - (670,972) 22,818 (7,145,283) 17,924 56,791,883 1,868,235 1,137,720 152,636,277 183,044 152,819,321 | Capital increase 276,930 - - - - - - - - - - - 276,930 - 276,930 | Transferred to reserves - 2,771,284 19,758,610 - - - 2,246 - - (21,744,828) (787,312) - - - - | Net profit for the period - - - - - - - - - 33,345,690 - - 33,345,690 946 33,346,636 | Dividends paid - - - - - - - - - (14,714,434) - - (14,714,434) (59,420) (14,773,854) | Transferred to RE from financial assets at fair value through OCI - - - - - - - 3,586 - (3,586) - - - - - | Transferred to general risk reserve - - - 26,186 - - - - - (26,186) - - - - - | Net change on financial assets at fair value through OCI after tax - - - - - - - 4,974,839 - - - - 4,974,839 82,006 5,056,845 | Transferred (from) to banking risk reserve - - - - - - - - (2,628) 2,628 - - - - - | Effect of ECL on debt instruments measured at fair value through OCI - - - - - - - 142,274 - - - - 142,274 - 142,274 | Cost of employees' stock ownership plan (ESOP) - - - - - - - - - - 653,254 - 653,254 - 653,254 | Cumulative foreign currencies translation differences - - - - - - - - - - - (215,827) (215,827) - (215,827) | Ending balance 30,708,510 8,979,958 82,181,402 1,577,092 - (670,972) 25,064 (2,024,584) 15,296 53,651,167 1,734,177 921,893 177,099,003 206,576 177,305,579 | Jun. 30, 2026 Issued and paid capital Legal reserve General reserve General risk reserve Special reserve Reserve for transactions under common control Capital reserve Reserve for financial assets at fair value through OCI Banking risks reserve Retained earnings Reserve for employee stock ownership plan Cumulative foreign currencies translation differences Total Shareholders' Equity Non-Controlling Interest Total | Beginning balance 33,779,361 8,979,958 79,110,551 1,577,092 13,145,012 (670,972) 25,064 2,825,146 15,296 89,514,273 2,343,532 842,029 231,486,342 27,876 231,514,218 | Capital increase 272,030 - - - - - - - - - - - 272,030 - 272,030 | Transferred to reserves - 4,089,832 31,449,216 - - - 13,005 - - (34,709,007) (843,046) - - - - | Dividends paid - - - - - - - - - (29,037,813) - - (29,037,813) (15,015) (29,052,828) | Net profit for the period - - - - - - - - - 39,313,459 - - 39,313,459 267 39,313,726 | Transferred to general risk reserve - - - (27,647) - - - - - 27,647 - - - - - | Net change on financial assets at fair value through OCI after tax - - - - - - - (3,867,224) - - - - (3,867,224) - (3,867,224) | Transferred (from) to banking risk reserve - - - - - - - - (8,804) 8,804 - - - - - | Effect of ECL on debt instruments measured at fair value through OCI - - - - - - - (942,320) - - - - (942,320) - (942,320) | Cost of employees' stock ownership plan (ESOP) - - - - - - - - - - 795,382 - 795,382 - 795,382 | Cumulative foreign currencies translation differences - - - - - - - - - - - 383,255 383,255 - 383,255 | Ending balance 34,051,391 13,069,790 110,559,767 1,549,445 13,145,012 (670,972) 38,069 (1,984,398) 6,492 65,117,363 2,295,868 1,225,284 238,403,111 13,128 238,416,239 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END IR SEUFASEMSELW